Form 8-K - Current report:
SEC Accession No. 0001493152-17-004418
Filing Date
2017-04-26
Accepted
2017-04-26 16:51:32
Documents
3
Period of Report
2017-04-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 28453
2 ex311.htm EX-3.1.1 13356
3 ex312.htm EX-3.1.2 10149
  Complete submission text file 0001493152-17-004418.txt   53198
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 300662986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54878 | Film No.: 17785039
SIC: 2834 Pharmaceutical Preparations